ArticleFrontiers in psychiatry2025
Gender differences in the prevalence and correlates of COVID-19 fear among mental health professionals: a network perspective based on a national survey in China.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder.Frontiers in public health · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gender differences in COVID-19-related fear among mental health professionals (MHPs) have been inadequately studied. This study compared the gender differences in prevalence, correlates and network structure of COVID-19 fear among MHPs in China in the post-pandemic era. Methods: A nationwide cross-sectional study was conducted between January 22 and February 10, 2023. Binary logistic regression was used to identify factors associated with COVID-19 fear. Expected Influence was used to identify the most central (influential) symptoms in gender-specific networks, while network comparison tests were conducted to assess the differences between male and female models. Results: Among 7,199 MHPs, the overall prevalence of COVID-19 fear was 63.5% (95% CI: 62.3%-64.6%), with 61.7% (95% CI: 58.9%-64.4%) in males and 65.0% (95% CI: 63.7%-66.2%) in females. For male MHPs, factors associated with COVID-19 fear included having married status (OR: 1.39; 95% CI: 1.02-1.90; P = 0.037), poorer economic status (poor vs. good: OR: 1.91; 95% CI: 1.23-2.98; P = 0.004), more severe insomnia (OR: 1.04; 95% CI: 1.01-1.07; P = 0.018), and depression (OR: 1.09; 95% CI: 1.05-1.12; P < 0.001). For female MHPs, the significant factors included having married status (OR: 1.21; 95% CI: 1.06-1.37; P = 0.004), poorer economic status (poor vs. good: OR: 1.39; 95% CI: 1.11-1.73; P = 0.004), more severe insomnia (OR: 1.05; 95% CI: 1.03-1.06; P < 0.001), depression (OR: 1.09; 95% CI: 1.08-1.11; P < 0.001), and quarantine experience (OR: 1.17; 95% CI: 1.04-1.30; P = 0.006). Network analysis revealed that the most central symptom in the male network was FOC6 (sleep difficulties due to COVID-19 concerns), while the corresponding node in the female network model was FOC7 (palpitations when thinking about COVID-19). Conclusion: COVID-19-related fear was more prevalent among female MHPs than males. Specific interventions targeting the central symptoms in each network should be implemented to alleviate COVID-19 fear effectively and improve the mental health of MHPs in the post-pandemic era.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.